Lorcaserin - Elixir or Liability?
- PMID: 30145932
- DOI: 10.1056/NEJMe1810855
Lorcaserin - Elixir or Liability?
Comment on
-
Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.N Engl J Med. 2018 Sep 20;379(12):1107-1117. doi: 10.1056/NEJMoa1808721. Epub 2018 Aug 26. N Engl J Med. 2018. PMID: 30145941 Clinical Trial.
Similar articles
-
Lorcaserin. In obesity: unacceptable risks.Prescrire Int. 2014 May;23(149):117-20. Prescrire Int. 2014. PMID: 24926508
-
Health-related quality of life in randomized controlled trials of lorcaserin for obesity management: what mediates improvement?Clin Obes. 2017 Dec;7(6):347-353. doi: 10.1111/cob.12207. Epub 2017 Aug 17. Clin Obes. 2017. PMID: 28815987 Clinical Trial.
-
New obesity agents: lorcaserin and phentermine/topiramate.Ann Pharmacother. 2013 Jul-Aug;47(7-8):1007-16. doi: 10.1345/aph.1R779. Epub 2013 Jun 25. Ann Pharmacother. 2013. PMID: 23800750 Review.
-
The safety and efficacy of lorcaserin in the management of obesity.Postgrad Med. 2013 Nov;125(6):62-72. doi: 10.3810/pgm.2013.11.2713. Postgrad Med. 2013. PMID: 24200762 Review.
-
Pharmacokinetic drug evaluation of extended release lorcaserin for the treatment of obesity.Expert Opin Drug Metab Toxicol. 2017 Aug;13(8):891-896. doi: 10.1080/17425255.2017.1344214. Epub 2017 Jul 11. Expert Opin Drug Metab Toxicol. 2017. PMID: 28636828 Review.
Cited by
-
Patient Characteristics Associated with Receipt of Prescription Weight-Management Medications Among Veterans Participating in MOVE!Obesity (Silver Spring). 2019 Jul;27(7):1168-1176. doi: 10.1002/oby.22503. Epub 2019 May 15. Obesity (Silver Spring). 2019. PMID: 31090207 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical